The Executive Roundtable Program fosters the growth of executive leadership by equipping participants with essential skills, knowledge, and a robust professional network. Designed to build a strong foundation in these areas, the program covers a wide range of topics, including corporate strategy, funding, business development, financing, and IPOs. The cohort, comprising 20–25 members, meets in person five times annually. Participants are rising women leaders at the VP level and above, representing diverse sectors within the life sciences industry. Sessions are led by volunteer EWIB moderators and rotating executive guest mentors, offering a dynamic and collaborative learning environment.
This yearlong program provides five in-person sessions tailored for VP and C-level women in life sciences, biopharma, and health tech, focusing on:
- Being Strategic and Intentional About Relationships
- Corporate Strategy: Private, Public & Business Development
- Finance 101
- Negotiation and Doing the Deal
- Board and Investor Relationship, Ethics and Navigating the World of Funding
- Requirements: VP or C-Level Title, active Women In Bio Membership, and commitment to attend all five sessions
Thank you to our Cohort Co-Moderators Tina Chang and Iris Grossman and our mentors, moderators, and panelists who championed the program throughout the year.
Guest Mentors
- Amanda Kay, PhD, Senior Partner and Chief Business Development Officer, Flagship Pioneering
- Arielle Jackson, President, Longwood Healthcare Leaders
- Christine Cole, Head of Philanthropy and Partnerships, The Termeer Foundation
- Danielle O’Neal, Senior Vice President, Life Sciences, Banc of California
- SueAnn Sheehan, Managing Director, Citizens Private Bank
- Adi Gilboa-Geffen, SVP Product R&D, Eleven Therapeutics
Panel Moderators
- Danielle O’Neal, Senior Vice President, Life Sciences, Banc of California
- SueAnn Sheehan, Managing Director, Citizens Private Bank
- Geeta Singh, CEO, GSI Advisory EIR – UIUC Enterprise Works
- Delia Silva, PhD, Managing Director, L.E.K. Consulting, Life Sciences
- Holley Ann Edyvane, Principal, Miramar Global
- Ramani Varanasi PhD, MBA, Managing Director/CEO, ReVive Advisors
- Imran Nasrullah, BD&L Executive
- Iris Grossman, PhD, Chief Therapeutics Officer, Eleven
- Karla MacDonald, Chief Corporate Affairs Officer, Entrada Therapeutics
- Laurie A. Burlingame, JD, MBA, Partner CBT & Life Sciences, Morgan Lewis & Bockius, LLP
- Sara Michelmore, Managing Director, Milestone-Advisors LLC
- Martina Rozumberkova, Principal, Control Risks
Panelists/Speakers
- Carolina Alarco, Founder and Principal, Bio Strategy Advisors
- Julie Feder, Chief Financial Officer, Aura Biosciences
- Katie Bodner Spielberg, Senior Associate, 5AM Ventures
- Jennifer Manning, Executive Vice President, Head of Credit Private Bank, Citizens Private Bank
- Marissa Gentile, Managing Director, Head Boston Preferred Banking, Citizens Private Bank
- Kait Oliveira, Wealth Advisor, Citizens Private Wealth Management
- Jing L. Marantz, MD, PhD, MBA, Senior Partner and Chief Business Development Officer, CMO, Scholar Rock
- Diala Ezzedine, PhD, Co-founder, Board of Directors, Differentiated Therapeutics
- Eileen McCullough, MBA, Managing Director, ConsultEMed / Executive-in-Residence, UCSF Innovation Ventures
- Christine Brennen, PhD, Managing Director, Vertex Ventures HC
- Beth Shafer, PhD, MA, MPhil, Venture Partner, Advisor, Mubadala Capital
- Eason Hahm, MBA, Director of Investment Banking, William Blair
- Stephanie Parker Palmer, Special Counsel, Cooley
- Vered Bisker-Leib, PhD Executive/Board Advisor, Former CEO of Compass Therapeutics
- Rachel Sha, MBA, CEO at Vaxess Technologies
- Ella Hood, MBA, Managing Director, Cherrystone Angel Group
- Karla MacDonald, Chief Corporate Affairs Officer, Entrada Therapeutics
- Laurie A. Burlingame, JD, MBA, Partner CBT & Life Sciences, Morgan Lewis & Bockius, LLP
- Sara Michelmore, Managing Director, Milestone-Advisors LLC
- Iris Grossman, PhD, Chief Therapeutics Officer, Eleven
- Martina Rozumberkova, Principal, Control Risks
Submitted by Iris Grossman
